Search This Blog

Monday, November 4, 2019

Deciphera Pharmaceuticals EPS misses by $0.12

Deciphera Pharmaceuticals (NASDAQ:DCPH): Q3 GAAP EPS of -$1.28 misses by $0.12.
Cash, cash equivalents and marketable securities of $635M.
Press Release
Posted by at

No comments:

Post a Comment

Note: Only a member of this blog may post a comment.

Subscribe to: Post Comments (Atom)